Prevalence of Cardiotoxic Cancer Medications in Australian Patients

A research study examines the prevalence of Australians exposed to potentially cardiotoxic cancer medications, particularly focusing on anthracyclines. The findings highlight a significant proportion of patients receiving these medications, with a particular impact on women undergoing breast cancer treatments and older age groups.